It is added because it addresses two specific and significant clinical problems that arise from GLP-1 receptor agonist therapy: nausea at treatment initiation and progressive B12 depletion over the course of long-term use
Motility and Metabolic Pharmacoepidemiology Group, Ma KS, et al
Error 2: Incorrect conversion from ml to mg The problem: Confusing milliliters (ml), a volume, with milligrams (mg), a mass
What TRICARE does not do is lay out those criteria in a way most patients can easily follow
Figure 28: Photograph of the gastrointestinal researchers at Bispebjerg Hospital in 1975, credit: Figure 1.3.3, Holst 2024
[7] Clinicians and patients should therefore rely on peer-reviewed trial publications and the oversight of trial ethics committees for safety information at this stage